E. Donnall Thomas’s Nobel Prize medal sells for $312,500

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.

May 24, 2024

Vol.50 No.21

Clinical Roundup

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

Patients in remission after being treated for a high-risk blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells.

May 03, 2024

Vol.50 No.18

In Brief

Nobel Laureate William Kaelin receives Fox Chases’s Stanley P. Reimann Honor Award

Jonathan Chernoff and William G. KaelinWilliam G. Kaelin Jr., physician, scientist, and Nobel laureate, was recognized at Fox Chase Cancer Center with the Stanley P. Reimann Honor Award, the center’s highest distinction.

April 05, 2024

Vol.50 No.14

In Brief

Damian Green named chief of Division of Transplantation & Cellular Therapy at Sylvester

Damian Green will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring to lead its transplantation and cellular therapy services. Green was named chief of the Division of Transplantation & Cellular Therapy, as well as assistant director of Translational Research, beginning March 1.

February 23, 2024

Vol.50 No.08

Clinical Roundup

UNM completes the first allogeneic stem cell transplant in the state

Doctors at the University of New Mexico Comprehensive Cancer Center successfully treated blood cancer patients using allogeneic stem cell transplant—a first for New Mexico.

January 19, 2024

Vol.50 No.03

In Brief

Katalin Karikó, Drew Weissman awarded 2023 Nobel Prize in Physiology or Medicine for mRNA vaccine research

Katalin Karikó (left) and Drew Weissman (right)Photo credit: Niklas Elmehed © Nobel Prize OutreachKatalin Karikó and Drew Weissman were jointly awarded the 2023 Nobel Prize in Physiology or Medicine “for their discoveries concerning base modifications that enabled the development of effective mRNA vaccines against COVID-19.”

October 13, 2023

Vol.49 No.38

E. Donnall Thomas’s Nobel Prize medal sells for $312,500

YOU MAY BE INTERESTED IN

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

Nobel Laureate William Kaelin receives Fox Chases’s Stanley P. Reimann Honor Award

Damian Green named chief of Division of Transplantation & Cellular Therapy at Sylvester

UNM completes the first allogeneic stem cell transplant in the state

Katalin Karikó, Drew Weissman awarded 2023 Nobel Prize in Physiology or Medicine for mRNA vaccine research

Renew today!

Subscriber content

Login